Notice2024-03241
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 16, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 33 (Friday, February 16, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 33 (Friday, February 16, 2024)]
[Notices]
[Pages 12347-12348]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-03241]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-1186]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Information Collection for Tuberculosis
Data from Referring Entities to CureTB'' to the Office of Management
and Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on December 15, 2023 to obtain comments from
the public and affected agencies. CDC did not receive comments related
to the previous notice. This notice serves to allow an additional 30
days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Information Collection for Tuberculosis Data from Referring
[[Page 12348]]
Entities to CureTB (OMB Control No. 0920-1186, Exp. 02/29/2024)--
Revision--National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The CureTB program works to prevent the spread of tuberculosis (TB)
among people who cross international borders. To reduce disease
transmission and the emergence of drug-resistant TB, CureTB connects
people with TB to healthcare services as they move between the United
States and other countries. The program is a collaboration between
CDC's Division of Global Migration Health (DGMH) and the County of San
Diego's Tuberculosis Control Program. CureTB collaborates with health
authorities throughout the United States and around the world to link
people with TB to care at their destinations. Health departments,
healthcare providers, and others seeking help in linking patients to
ongoing TB care in other countries can refer patients to CureTB.
Information will be collected from the referring entities, which
are State and local health departments and Federal immigration and
detention agencies. Whenever the referring entities provide clinical
services to an individual with TB who has imminent plans to relocate,
and an individual needs continuity of care in their new location, CDC
CureTB is contacted to assist with coordinating that care. TB patients
may also be a respondent if critical clinical or contact data is
missing and requires follow-up by CureTB to complete a patient's
referral information set. The request for CDC CureTB services comes
from the referring entities and they supply the information at the time
the patient is likely to leave their jurisdiction. The referring
entities update information only if relevant information to the
patient's care becomes available to them after their first
communication with CDC CureTB. Therefore, information is already
largely collected by CDC CureTB only at one point in time, with
subsequent information only collected if departure is delayed or when
initially pending information becomes available and this is beyond the
control of CDC.
Post relocation of the TB patient, data is also collected from the
receiving physicians to determine patient outcomes. CDC CureTB contacts
the physician an average of every two months during the standard six-
month TB treatment process. The data provides valuable information on
globally mobile populations and allows CDC to assist in continuity of
TB care and monitor the effectiveness of the program.
The continuous expansion and use of the CureTB Program requires
certain processes be evaluated. The Supplemental CureTB Program Partner
Satisfaction Assessment Questionnaire will guide CureTB in making
appropriate program improvements to best serve referring partners. The
Questionnaires will not be used to collect demographic or clinical
information, rather, they will ask the referring partners about their
experience separately from the other forms already used for demographic
and clinical information for each patient.
As part of this revision request, CureTB is updating the number of
respondents and total burden hours. There are no changes to the data
collection instruments. CDC requests OMB approval for an estimated
1,139 annual burden hours. There are no costs to respondents other than
their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response
respondent (in hours)
----------------------------------------------------------------------------------------------------------------
U.S. Health Departments................ CureTB Transnational 100 3 30/60
Notification.
TB patients referred by U.S. health CureTB Transnational 200 1 5/60
departments. Notification.
TB patients referred by ICE............ CureTB Transnational 600 1 45/60
Notification.
TB treating physicians in new country.. CureTB Telephone Script 900 3 10/60
Clinician/foreign health
authority Referral Follow-
up.
U.S. Health Departments................ CureTB Contact/Source 20 5 30/60
Investigation (CI/SI)
Notification.
U.S. Health Department (Local & State). CureTB Partner Feedback 100 1 10/60
(Satisfaction
Assessment)--Questionnair
e 1.
U.S. Health Department................. CureTB Partner Feedback 50 1 6/60
(Satisfaction
Assessment)--Questionnair
e 2.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-03241 Filed 2-15-24; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on February 16, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.